Tarlatamab for Previously Treated Small Cell Lung Cancer
UPDATE: On May 16, the Food and Drug Administration approved tarlatamab (Imdelltra) to treat people with extensive-stage small cell lung cancer whose disease has worsened while receiving or after receiving platinum-based chemotherapy. The approval was based on findings from the DeLLphi-301 clinical trial described below. Under the accelerated approval, Amgen, the drug’s maker, must conduct ...
AI tool ‘sees’ cancer gene signatures in biopsy images | News …
1 day ago · November 14, 2024 - By Sarah C.P. Williams. A new AI program, SEQUOIA, can analyze a microscopy image from a tumor biopsy (left, purple) and rapidly determine what genes are likely turned on and off in the cells it contains (gene expression shown in shades of red and blue on right). To determine the type and severity of a cancer, pathologists ...
Mathematical modeling leads to a better understanding of prostate cancer
15 hours ago · Mathematical modeling leads to a better understanding of prostate cancer. Credit: Cell Systems (2024). DOI: 10.1016/j.cels.2024.10.005. A team led by Dr. Yuri Tolkach at the University of Cologne ...
Toripalimab For Extensive-Stage Small Cell Lung Cancer
1 day ago · Small cell lung cancer (SCLC) is an aggressive malignancy characterized by rapid tumor growth and the early development of distant metastases, with approximately 70% of patients presenting with metastatic or extensive-stage (ES) SCLC. The current standard treatment for ES-SCLC in most parts of the world includes the combination of platinum ...
Toripalimab Plus Chemotherapy as a First-Line Therapy for …
1 day ago · Importance Patients with extensive-stage small cell lung cancer (ES-SCLC) have poor prognoses and unmet medical needs.. Objective To evaluate the efficacy and safety of toripalimab plus etoposide and platinum-based chemotherapy (EP) vs placebo plus EP as a first-line treatment for patients with ES-SCLC.. Design, Setting, and Participants This multicenter, double-blind, placebo-controlled phase ...
An experimental cancer drug had a 100% success rate : NPR
Jun 7, 2022 · A tiny group of people with rectal cancer just experienced something of a scientific miracle: their cancer simply vanished after an experimental treatment.
Cancer Staging - NCI - National Cancer Institute
Staging is the process of determining how much cancer is within the body (tumor size) and if it has spread. Learn about the TNM Staging system and other ways that stage is described.
Stages of Cancer: What They Mean & How Staging Works - Cleveland Clinic
Stage I (1) cancer: The tumor is smaller and contained to one area. It hasn’t spread to nearby lymph nodes or other areas of your body. Stage II (2) cancer: The tumor has grown larger and possibly spread to nearby lymph nodes. Stage III (3) cancer: The tumor has grown deeper into surrounding tissues and has potentially spread to nearby lymph ...
People with pancreatic cancer are living longer, thanks to …
Nov 15, 2022 · Initial testing and staging of pancreatic cancer can help uncover weaknesses or potential threats for each unique pancreatic cancer case.
Cancer Staging | Has Cancer Spread | Cancer Prognosis
Along with the TNM (and other) staging systems, cancers can also be staged in a simpler way, using the US National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Summary Staging system. To learn more, see ‘Cancer staging for statistics purposes,’ below.